You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
联康生物科技(00690.HK):正致力将Uni-GLP扩展到治疗2019冠状病毒病和其他适应症
阿思达克 09-18 17:51
联康生物科技集团(00690.HK)公布,对於Uni-GLP在新的治疗领域的发展潜力保持乐观态度。集团已经和中国的几所大学合作,开展Uni-GLP治疗肥胖症的临床前研究,以及开发创新口服剂型或者第三代Uni-GLP。有了GLP-1RAs在心血管疾病、非酒精性脂肪肝病、非酒精性脂性肝炎、阿尔兹海默症和COVID-19治疗中的最新数据,集团目前正在与国家药品监督管理局(NMPA)和潜在合作夥伴进行谈判,以将Uni-GLP扩展到这些新的领域。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account